Syndax Pharmaceuticals (SNDX) Share-based Compensation (2015 - 2026)
Syndax Pharmaceuticals' Share-based Compensation was $15.29 million in Q3 2026, up 26.5% from $12.08 million a year earlier and up 9.1% from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Share-based Compensation (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Syndax Pharmaceuticals' Share-based Compensation was $52.61 million through Sep 30, 2026, up 8.4% year-over-year; for FY2025, it was $47.5 million, up 10.4% from FY2024.
- Share-based Compensation has now increased for six consecutive years, with a five-year compound annual growth rate of 39.3% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $43.03 million in FY2024 (+39.0%), $30.95 million in FY2023 (+93.2%), $16.02 million in FY2022 (+20.3%) and $13.32 million in FY2021 (+47.0%).
- The Q3 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q1 2015.
- Compared with a year earlier, Share-based Compensation has increased for three straight quarters, with growth averaging 17.6% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2023 (growth of 104.8%); the worst was Q4 2025 (a decline of 8.5%).
- Per Business Quant data, SNDX's Share-based Compensation in the three quarters before Q3 2026 was $14.01 million (Q2 2026), $12.05 million (Q1 2026) and $11.25 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Syndax Pharmaceuticals | 871.86 Mn | -849.24 Mn | 69.30 Mn | 15.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.29 Mn |
| Jun 30, 2026 | 14.01 Mn |
| Mar 31, 2026 | 12.05 Mn |
| Dec 31, 2025 | 11.25 Mn |
| Sep 30, 2025 | 12.08 Mn |
| Jun 30, 2025 | 13.79 Mn |
| Mar 31, 2025 | 10.38 Mn |
| Dec 31, 2024 | 12.30 Mn |
| Sep 30, 2024 | 11.93 Mn |
| Jun 30, 2024 | 9.90 Mn |
| Mar 31, 2024 | 8.90 Mn |
| Dec 31, 2023 | 8.33 Mn |
| Sep 30, 2023 | 8.32 Mn |
| Jun 30, 2023 | 8.07 Mn |
| Mar 31, 2023 | 6.24 Mn |
| Dec 31, 2022 | 4.24 Mn |
| Sep 30, 2022 | 4.36 Mn |
| Jun 30, 2022 | 3.94 Mn |
| Mar 31, 2022 | 3.48 Mn |
| Dec 31, 2021 | 3.93 Mn |
API Access
Syndax Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();